Literature DB >> 2864975

Muscarinic receptors discriminated by pirenzepine are involved in the regulation of neurotransmitter release in rat nucleus accumbens.

J de Belleroche, I M Gardiner.   

Abstract

The effect of pirenzepine, a selective muscarinic antagonist, was tested on the oxotremorine facilitation of the K+-evoked release of [14C]-dopamine from tissue slices of rat nucleus accumbens. The effect of pirenzepine was compared with that of scopolamine and other antagonists which show no heterogeneity in their action on muscarinic receptors in order to determine whether a selective action at a single receptor subtype, M1 or M2, could be distinguished. Pirenzepine and scopolamine both antagonized the oxotremorine-induced (EC50 = 3 X 10(-7) M) facilitation of [14C]-dopamine release with pA2 values of 7.5 and 8.9 respectively. This result indicated that the high affinity pirenzepine receptor (M1) was involved in this response. Low concentrations of 3-quinuclidinyl benzilate (3 X 10(-10) M), N-methylscopolamine (3 X 10(-9) M) and methyl atropine (10(-8) M) also abolished this facilitatory effect of oxotremorine.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2864975      PMCID: PMC1916685          DOI: 10.1111/j.1476-5381.1985.tb08921.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  14 in total

1.  Depression of acetylcholine release from cerebral cortical slices by cholinesterase inhibition and by oxotremorine.

Authors:  J C Szerb; G T Somogyi
Journal:  Nat New Biol       Date:  1973-01-24

2.  The character of the muscarinic receptors in different regions of the rat brain.

Authors:  N J Birdsall; E C Hulme; A Burgen
Journal:  Proc R Soc Lond B Biol Sci       Date:  1980-02-13

3.  Antagonist discrimination between ganglionic and ileal muscarinic receptors.

Authors:  D A Brown; A Forward; S Marsh
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

4.  Muscarinic receptor subtypes: M1 and M2 biochemical and functional characterization.

Authors:  R Hammer; A Giachetti
Journal:  Life Sci       Date:  1982-12-27       Impact factor: 5.037

5.  The contrasting effects of neuroleptics on transmitter release from the nucleus accumbens and corpus striatum.

Authors:  J S de Belleroche; M J Neal
Journal:  Neuropharmacology       Date:  1982-06       Impact factor: 5.250

6.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

7.  The effects of atropine on [3H]acetylcholine secretion from guinea-pig myenteric plexus evoked electrically or by high potassium.

Authors:  P Alberts; T Bartfai; L Stjärne
Journal:  J Physiol       Date:  1982-08       Impact factor: 5.182

8.  A unique regulatory profile and regional distribution of [3H]pirenzepine binding in the rat provide evidence for distinct M1 and M2 muscarinic receptor subtypes.

Authors:  M Watson; H I Yamamura; W R Roeske
Journal:  Life Sci       Date:  1983-06-27       Impact factor: 5.037

9.  Pre- and postjunctional effects of prostaglandin E2, prostaglandin synthetase inhibitors and atropine on cholinergic neurotransmission in guinea pig ileum and bovine iris.

Authors:  L Gustafsson; P Hedqvist; G Lundgren
Journal:  Acta Physiol Scand       Date:  1980-12

10.  Involvement of cholinergic presynaptic receptors of nicotinic and muscarinic types in the control of the spontaneous release of dopamine from striatal dopaminergic terminals in the rat.

Authors:  M F Giorguieff; M L Le Floc'h; J Glowinski; M J Besson
Journal:  J Pharmacol Exp Ther       Date:  1977-03       Impact factor: 4.030

View more
  2 in total

1.  Presynaptic muscarinic and alpha-adrenoceptor-mediated regulation of GABA release from myenteric neurones of the guinea-pig small intestine.

Authors:  S Hashimoto; C Tanaka; K Taniyama
Journal:  Br J Pharmacol       Date:  1986-12       Impact factor: 8.739

2.  A quantitative study of the effects of some muscarinic antagonists on the guinea-pig olfactory cortex slice.

Authors:  S H Williams; A Constanti
Journal:  Br J Pharmacol       Date:  1988-04       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.